Medicare
Cue Health awarded $481M for coronavirus testing; public hospitals compounding COVID-19 budget risks
This week's top stories include Cue expecting to deliver six million COVID-19 molecular tests by March, while surging costs and revenue loss force hospitals to rely on support from county governments.
The updated version of the company's system includes automatic alerts when the wearer's glucose is too high or too low.
The Epstein Becker Green report pinpointed the opioid epidemic as a major driving force behind new laws and programs, but coverage restrictions and non-robust parity laws are still hampering adoption within Medicare.
As politicians and their constituents grapple over Medicare for All, these well-funded startups hope to capitalize on the public’s appetite for new, consumer-friendly approaches to health insurance.
Also: Propeller Health CCO warns against unchecked disruption; Grant brings smartphone diabetic retinopathy screening to India.
Researchers say 99.7% of physicians' profiles lack individual quality data and 77% lack group data.
The app lets those on Medicare search for products and services to see if they are covered.
Also: New funding announcements from Nomad Health and Powerdot.
CMS Administrator Seema Verma said that the remote monitoring change and others would promote care innovation and reduce provider burden.